Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Exacerbation of inflammatory bowel disease by nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors: fact or fiction?

Literature DB >> 16570341

Exacerbation of inflammatory bowel disease by nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors: fact or fiction?

Abstract

The existence of a possible link between inflammatory bowel disease (IBD) and nonsteroidal anti-inflammatory drugs (NSAIDs) has been repeatedly suggested. Recently, a few studies have addressed the issue of a possible, similar effect by selective cyclooxygenase-2 inhibitors (COXIBs). The present article reviews the available scientific evidence for this controversial subject.

Entities: Disease Gene

Mesh：

Substances：

Year: 2006 PMID： 16570341 PMCID： PMC4124281 DOI： 10.3748/wjg.v12.i10.1509

Source DB: PubMed Journal: World J Gastroenterol ISSN： 1007-9327 Impact factor: 5.742

18 in total

1. Using COX-2 inhibitors in IBD: anti-inflammatories inflame a controversy.

Authors: Gregory F Bonner
Journal: Am J Gastroenterol Date: 2002-04 Impact factor: 10.864

Review 2. Nonsteroidal anti-inflammatory drugs in patients with inflammatory bowel disease.

Authors: J O'Brien
Journal: Am J Gastroenterol Date: 2000-08 Impact factor: 10.864

3. Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study.

Authors: J B Felder; B I Korelitz; R Rajapakse; S Schwarz; A P Horatagis; G Gleim
Journal: Am J Gastroenterol Date: 2000-08 Impact factor: 10.864

4. Selective cyclooxygenase-2 inhibitors and relapse of inflammatory bowel disease.

Authors: Livia Biancone; Claudio Tosti; Francesca De Nigris; Massimo Fantini; Francesco Pallone
Journal: Gastroenterology Date: 2003-08 Impact factor: 22.682

Review 5. Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: current perspectives.

Authors: Giovanna Cipolla; Francesca Crema; Stefano Sacco; Elisabetta Moro; Fabrizio de Ponti; Gianmario Frigo
Journal: Pharmacol Res Date: 2002-07 Impact factor: 7.658

Review 6. Systematic review: is ingestion of paracetamol or non-steroidal anti-inflammatory drugs associated with exacerbations of inflammatory bowel disease?

Authors: K Forrest; D Symmons; P Foster
Journal: Aliment Pharmacol Ther Date: 2004-11-15 Impact factor: 8.171

7. Clinical and endoscopic features of nonsteroidal anti-inflammatory drug-induced colonic ulcerations.

Authors: K Kurahara; T Matsumoto; M Iida; K Honda; T Yao; M Fujishima
Journal: Am J Gastroenterol Date: 2001-02 Impact factor: 10.864

8. Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease.

Authors: Uma Mahadevan; Edward V Loftus; William J Tremaine; William J Sandborn
Journal: Am J Gastroenterol Date: 2002-04 Impact factor: 10.864

Review 9. Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine.

Authors: S Smale; J Tibble; G Sigthorsson; I Bjarnason
Journal: Best Pract Res Clin Gastroenterol Date: 2001-10 Impact factor: 3.043

10. An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia.

Authors: W Reinisch; W Miehsler; C Dejaco; M Harrer; T Waldhoer; C Lichtenberger; H Vogelsang
Journal: Aliment Pharmacol Ther Date: 2003-06-01 Impact factor: 8.171

9 in total

1. Effect of cyclooxygenase genotype and dietary fish oil on colonic eicosanoids in mice.

Authors: Andrew P Neilson; Zora Djuric; Jianwei Ren; Yu H Hong; Ananda Sen; Corey Lager; Yan Jiang; Shony Reuven; William L Smith; Dean E Brenner
Journal: J Nutr Biochem Date: 2011-09-19 Impact factor: 6.048

Review 2. Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations.

Authors: Paul E Evans; Darrell S Pardi
Journal: MedGenMed Date: 2007-03-19

3. Intestinal epithelial cell-derived μ-opioid signaling protects against ischemia reperfusion injury through PI3K signaling.

Authors: Jason R Goldsmith; Ernesto Perez-Chanona; Prem N Yadav; Jennifer Whistler; Bryan Roth; Christian Jobin
Journal: Am J Pathol Date: 2013-01-02 Impact factor: 4.307

4. Cox-2 deletion in myeloid and endothelial cells, but not in epithelial cells, exacerbates murine colitis.

Authors: Tomo-O Ishikawa; Masanobu Oshima; Harvey R Herschman
Journal: Carcinogenesis Date: 2010-12-14 Impact factor: 4.944

5. Bradykinin stimulates protein kinase D-mediated colonic myofibroblast migration via cyclooxygenase-2 and heat shock protein 27.

Authors: Eric Chu; Shyla Saini; Tiegang Liu; James Yoo
Journal: J Surg Res Date: 2016-10-20 Impact factor: 2.192

Review 6. Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?

Authors: Helenie Kefalakes; Theodoros J Stylianides; George Amanakis; George Kolios
Journal: Eur J Clin Pharmacol Date: 2009-08-27 Impact factor: 2.953